Peritumoural CCL1 and CCL22 expressing cells in hepatocellular carcinomas shape the tumour immune infiltrate.
Adult
Aged
Aged, 80 and over
CD8-Positive T-Lymphocytes
/ metabolism
Carcinoma, Hepatocellular
/ metabolism
Chemokine CCL1
/ metabolism
Chemokine CCL22
/ metabolism
Female
Forkhead Transcription Factors
/ metabolism
Humans
Liver Neoplasms
/ metabolism
Lymphocytes, Tumor-Infiltrating
/ metabolism
Male
Middle Aged
T-Lymphocytes, Regulatory
/ metabolism
Young Adult
CCL1
CCL22
HCC
chemokines
regulatory T cell
Journal
Pathology
ISSN: 1465-3931
Titre abrégé: Pathology
Pays: England
ID NLM: 0175411
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
28
12
2018
revised:
16
05
2019
accepted:
06
06
2019
pubmed:
26
8
2019
medline:
29
2
2020
entrez:
26
8
2019
Statut:
ppublish
Résumé
Development, course of disease and prognosis of hepatocellular carcinomas (HCC) are strongly influenced by the immune system. Immunosuppressive regulatory T cells (Treg) have been shown to negatively impact disease progression and survival. To further understand the mechanisms of Treg attraction to HCC lesions, this study provides an analysis of Treg attracting chemokines in human HCC tissues. We analysed the expression of the Treg attracting chemokines CCL1 and CCL22 as well as the infiltration of FoxP3+ Treg and CD8+ T cells in paraffin-embedded tissue sections of 62 HCC patients. Expression of both chemokines was detected in 47 of 62 tissue slides. Chemokine expression was generally higher in tumour stroma and peritumoural liver tissue than in the tumour tissue itself. CD8+ T cells and FoxP3+ Treg were found at high levels in many tumour tissues. Intratumoural infiltration of Treg positively correlated with CCL22 levels in peritumoural liver tissue. In contrast, no correlation of Treg numbers and expression of CCL1 was detected. In summary, we describe here that the chemokines CCL1 and CCL22 are expressed in HCC tissues and, to a higher extent, in the stroma and peritumoural liver tissue. CCL22 may contribute to Treg recruitment and immunosuppression, whereas the role of CCL1 remains to be defined. It will be interesting to investigate the potential of these chemokines as drug targets for cancer therapy.
Identifiants
pubmed: 31445808
pii: S0031-3025(19)30328-9
doi: 10.1016/j.pathol.2019.06.001
pii:
doi:
Substances chimiques
CCL22 protein, human
0
Chemokine CCL1
0
Chemokine CCL22
0
FOXP3 protein, human
0
Forkhead Transcription Factors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
586-592Informations de copyright
Copyright © 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.